Home/Filings/4/0000899243-21-017261
4//SEC Filing

Green John L. 4

Accession 0000899243-21-017261

CIK 0001622229other

Filed

Apr 27, 8:00 PM ET

Accepted

Apr 28, 8:30 PM ET

Size

5.5 KB

Accession

0000899243-21-017261

Insider Transaction Report

Form 4
Period: 2021-04-26
Green John L.
Chief Financial Officer
Transactions
  • Sale

    Common Stock

    2021-04-26$8.86/sh17,813$157,8233,841 total
Footnotes (2)
  • [F1]The shares were sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units previously granted to the Reporting Person.
  • [F2]The price reported in Column 4 was the weighted-average sale price of the shares. The shares were sold in multiple transactions at prices ranging from $8.80 to $8.90. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the SEC Staff, upon request, full information regarding the number of shares sold at each price within the range set forth herein.

Issuer

Cogent Biosciences, Inc.

CIK 0001622229

Entity typeother

Related Parties

1
  • filerCIK 0001709773

Filing Metadata

Form type
4
Filed
Apr 27, 8:00 PM ET
Accepted
Apr 28, 8:30 PM ET
Size
5.5 KB